You are reading the report for 2026-08-19. The figures are as they stood that day and are not revised. See the current report →
Daily Special Report
Published Aug 20
Where the analysts disagree
The widest disagreement sits at DLTR: 2 up / 2 down, the biggest split of the 3 here. At the other end, MRNA is 2 up / 0 down, the smallest split of the 3 here. NVDA is 1 up / 2 down, while TGT is —, the only one here with that mark.
At DLTR, analysts divide 2 up / 2 down, the biggest split of the 3 here and the only one here with that balance. The gap between its target and price is —, matching NVDA's.
split: 2 up, 2 down · Cowen & Co., Goldman Sachs, Morgan Stanley
By contrast, NVDA has 1 up / 2 down, the second-largest split of the 3 here and the only one here with that balance. Its gap between target and price is —, shared with DLTR.
split: 1 up, 2 down · Morgan Stanley, RBC Capital, William Blair
For MRNA, the views run 2 up / 0 down, the smallest split of the 3 here and the only one here with that balance. Its gap between target and price is +77%, the biggest gap between target and price of the 2 here. Targets span $120 – $245, the only disclosed band of that size here.
targets $120-$245 · Bank of America Securities, D.A. Davidson, Goldman Sachs
Unlike the others, TGT has no split, shown as —, making it the only one here with that mark. Its gap between target and price is -13%, the smallest gap between target and price of the 2 here, while its disclosed band is $140 – $185, the biggest disclosed band of the 2 here.
targets $140-$185 · Barclays, D.A. Davidson
Grade changes and price targets published in the latest analyst feed. “Target vs price” compares the most recent target with the price at the time it was set. Analyst opinion is not a recommendation.